0.8802
-0.0402
(-4.37%)
At close: April 17 at 8:01:18 AM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
448,533
629,604
480,847
679,334
Total Liabilities Net Minority Interest
580,523
823,029
618,265
581,608
Total Equity Gross Minority Interest
-131,990
-193,425
-137,418
97,726
Total Capitalization
132,937
279,944
333,640
506,006
Common Stock Equity
-131,990
-193,425
-137,418
97,726
Capital Lease Obligations
4,977
7,473
9,364
10,743
Net Tangible Assets
-185,636
-265,098
-143,349
94,163
Working Capital
58,602
143,860
242,540
436,996
Invested Capital
132,937
279,944
333,640
506,006
Tangible Book Value
-185,636
-265,098
-143,349
94,163
Total Debt
269,904
480,842
480,422
419,023
Net Debt
138,940
370,478
407,511
--
Share Issued
115,213.4070
112,215.2600
78,851.5160
76,930.0960
Ordinary Shares Number
115,213.4070
112,215.2600
78,851.5160
76,930.0960
12/31/2021 - 11/22/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CXF.F Chimerix, Inc.
7.48
+0.27%
4AJ0.BE Alk-Abello A/S
19.68
+2.23%
4QK.F Codexis, Inc.
1.8460
+0.65%
IPIX Innovation Pharmaceuticals Inc.
0.0002
0.00%
NEUP Neuphoria Therapeutics Inc.
5.14
+0.38%
TSVT 2seventy bio, Inc.
4.9800
+0.20%
AEON AEON Biopharma, Inc.
0.4050
+1.28%
CMRX Chimerix, Inc.
8.54
-0.12%
ATOS Atossa Therapeutics, Inc.
0.6231
+2.99%